Psilocybin mushrooms, similar to LSD in that they act as serotonin 5-HT2A receptor agonists, are a type of traditional psychedelic. Presently, researchers are examining their potential application in psilocybin-assisted therapy for several mental health disorders. These include major depression, emotional distress, anxiety, cluster headaches, and migraines.
In order to understand how shrooms can help with these conditions, it is essential to delve into how they are metabolized in the body. This knowledge can aid researchers and users in understanding how the active compound triggers both psychological and therapeutic effects. This article offers a basic overview of the pharmacology and pharmacokinetics of psilocybin.
[toc]
Key Points:
- When consumed orally, the body absorbs and distributes half of these psychedelic fungi.
- The fungi’s compound undergoes a process called dephosphorylation, facilitated by the enzyme alkaline phosphatase, mainly in the liver.
- Approximately 3.4% of the compound is expelled in its original form within 24 hours, with most of it being excreted as a stable metabolite.
What Does Pharmacokinetics Mean?
Pharmacokinetics (PK) refers to the study of how substances like drugs are processed by the body after entering the system. While related to pharmacodynamics–the study of how a compound interacts with the body–PK focuses on four main aspects: absorption, distribution, metabolism, and excretion (ADME).
This understanding enables healthcare professionals to prescribe the most effective medications with the least possible risk. It also aids in customizing treatments to suit each patient’s individual physiology and lifestyle.
How Does Pharmacokinetics Relate to Psilocybin?
Psilocybin and psilocin, the primary active compounds in certain magic mushroom species, have generated significant interest among both researchers and users. Pharmacokinetics investigates how the body interacts with mushrooms containing psilocybin, shedding light on their potential effects, whether medicinal or recreational.
These compounds, referred to by various names like “magic,” “psychedelic,” “medicinal,” or “sacred,” are found in fungi that are consumed. The Mushroom species, their place of origin, physical size, growth and drying conditions, and age can bring about substantial differences in their concentration levels.
These mushrooms naturally exist in the wild, but scientists have also devised ways to produce them synthetically in labs. Both the wild and lab-grown mushrooms exhibit low toxicity levels, although they may cause minor side effects like nausea or vomiting.
Despite these physical side effects, the compounds present in these mushrooms have demonstrated potential therapeutic benefits. This is because they are safe and non-addictive. Such benefits have sparked interest among researchers in exploring their use in psychotherapy, particularly for treating anxiety and depression.
The 4 Phases of Pharmacokinetics
Psilocybin, the primary compound in these mushrooms, is initially inactive and functions as a prodrug. It converts into its active form, psilocin, with the help of enzymes such as alkaline phosphatase. This conversion enables psilocin to be absorbed and distributed throughout the body, reaching various tissues. However, psilocybin is not detectable in the circulatory system, feces, or urine after oral administration.
Absorption
Absorption is the process that allows the compound to enter the bloodstream from the site of administration. It affects the rate and effectiveness of the compound reaching its target, like the plasma. Oral administration is the most commonly used method. Inhalation has also been tried, but it’s not as efficient as ingestion.
The process of absorption also includes the release of the compound from the dosage form during oral intake. Factors like delays in the throat or esophagus can affect this, potentially reducing efficacy or causing discomfort. When the compound reaches the stomach, the acidic environment may start to degrade it before it enters the bloodstream.
Studies on animals suggest that only about 50% of orally administered psychedelics are absorbed and distributed throughout the body.
Factors Affecting the Absorption Process
Various factors can influence the absorption process, leading to variations in the onset, intensity, and duration:
- Stomach Contents: A full stomach can delay the absorption process as it slows down the onset of effects. Conversely, an empty stomach allows for quicker absorption.
- Body Fat: Compounds may accumulate in fat tissues, potentially prolonging their effects.
- Age: Metabolism rates and body composition often vary with age.
- Zero-Order Kinetics: The substance is cleared at a steady rate, regardless of its concentration.
- First-Order Kinetics: The elimination rate is proportional to the concentration of the drug.
Dispersion refers to the distribution of psilocin throughout the body once it enters the bloodstream. As a lipophilic compound, psilocin can penetrate the blood-brain barrier and access the central nervous system.
system.Various factors, such as the size, polarity, and protein-binding capability of the substance, along with the individual’s physiology—like hydration status and body composition—significantly influence this process.
The goal is to establish a potent concentration at the target site. To be effective, the substance must reach the intended location, as defined by the volume of distribution, and remain unattached to proteins, allowing it to actively interact with its receptor.
What Factors Affect the Dispersion Processes?
Several elements can impact the dispersion process:
Typically, the effects begin to manifest between 20 and 40 minutes after ingestion, peaking around 80 to 100 minutes. The effects of magic mushrooms usually persist for 4-6 hours.
How is Dispersion to the Brain Achieved?
In a preliminary experimental study conducted on two species, it was found that the order of binding affinity is 5HT2A > 5HT1A > 5HT2B [23]. It also binds to dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
It acts as a partial agonist at the 5HT2A receptor, with an efficacy of about 40%. The psychedelic effects can be traced back to its partial agonist activity at 5HT1A autoreceptors.
The mood-enhancing and psychotomimetic experiences may be due to the observed correlation between increased dopamine levels and sensations of depersonalization and euphoria. Hallucinogens work by modifying neurochemistry and receptor activity. It enhances 5HT2A agonist activity by boosting BDNF synthesis in the hippocampus, which subsequently stimulates neurogenesis and reduces conditioned fear-related behaviors.
Elimination
Elimination refers to the process by which the The body excretes a substance mainly through the kidneys, but also via the lungs, skin, and gastrointestinal tract. In relation to the kidneys, a naturally occurring psychedelic drug is filtered at the glomerulus or secreted in the tubules. The process is complicated by some reabsorption.
The primary compound has a half-life of about 160 minutes, while psilocin’s half-life is roughly 50 minutes. Animal studies indicate that most of it is excreted in the urine, accounting for around 65% within 8 hours after consumption. Even after this, smaller amounts of the substance can be found in bile and feces.
In humans, around 3.4% of the substance is excreted in its original form within 24 hours. The bulk is eliminated as psilocin-O-glucuronide, a metabolite that is more stable. This stability enables the compound to be detected in urine samples over a longer duration.
There are two primary mechanisms for substance elimination:
Most psychedelic drugs are eliminated according to the first-order kinetics model, reaching stable concentrations after four to five half-lives. Complete elimination also occurs after around four to five half-lives.
Discover Our Range of Hallucinogenic Mushrooms
The metabolic process differs among various kinds of fungi. By shopping from reliable online providers like Microdosing Mushrooms Canada, you can avoid inadvertently ingesting poisonous mushrooms. Some varieties, like Agaric mushrooms, might cause intense and undesirable effects. Therefore, it’s essential to purchase magic mushrooms from trusted sources, rather than risky street vendors or foraging in the wild.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Exceptionally high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Looks like a blob or | Resembles a cauliflower or brain structure | Exhibits a typical cubensis appearance; moderately sized | Features thick white stems; golden caramel caps; visible blue bruising |
| Effects | Known to be the most potent; induces intense effects | Provides a strong mental high; onset delay with significant visuals | Generates vivid visuals and euphoria |
Explore Psilocybin Mushroom Usage Online
Grasping the pharmacokinetics of shrooms is crucial for medical professionals, researchers, and users. Armed with this knowledge, you can make educated decisions regarding dosage and timing, thereby reducing potential risks.
Discover your perfect psychedelic experience at Microdosing Mushrooms Canada. Whether you’re looking for a tranquil journey or a deeper exploration, our wide variety of products is designed to meet your unique needs. Enjoy premium, safe, and quality-controlled shrooms, eliminating worries about unverified sources or poisonous mushrooms.
Sample the best magic mushrooms Canada has to offer and take your psychedelic journey to new heights.
Frequently Asked Questions
Are there any known interactions between shrooms and other medications?
Our products may interact with certain medications, particularly those that affect serotonin levels, such as SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) typically lessen the effects, unlike non-serotonergic antidepressants. This reduced effect can last for up to three months after discontinuing the use of the antidepressant.
Do all psychedelics follow the same pathway as psilocybin?
No, each psychedelic substance has a unique structure that requires different metabolic processes to activate, and they bind to different receptors within the body. The route of administration also affects the absorption of each psychedelic. While the basic principles of absorption, metabolism, and distribution stay the same, the specific pathways and effects vary for each substance.
Can the form of the shroom impact the pharmacokinetics?
Yes, the form (whether fresh, powdered, or dried mushrooms) can influence the absorption rate. For example, powdered forms might be absorbed more quickly than whole dried ones due to faster dissolution.
Suggested Reads:
